INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 145 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 2.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $210,000 | +72.1% | 10,000 | 0.0% | 0.11% | +35.4% |
| Q1 2020 | $122,000 | -17.0% | 10,000 | 0.0% | 0.08% | +8.2% |
| Q4 2019 | $147,000 | +9.7% | 10,000 | 0.0% | 0.07% | 0.0% |
| Q3 2019 | $134,000 | -18.3% | 10,000 | 0.0% | 0.07% | -19.8% |
| Q2 2019 | $164,000 | -4.1% | 10,000 | 0.0% | 0.09% | -9.0% |
| Q1 2019 | $171,000 | +25.7% | 10,000 | 0.0% | 0.10% | +12.4% |
| Q4 2018 | $136,000 | -52.4% | 10,000 | 0.0% | 0.09% | -42.9% |
| Q3 2018 | $286,000 | -41.0% | 10,000 | -50.0% | 0.16% | +13.9% |
| Q2 2018 | $485,000 | +129.9% | 20,000 | +100.0% | 0.14% | +14.2% |
| Q1 2018 | $211,000 | -45.1% | 10,000 | -50.0% | 0.12% | +14.3% |
| Q4 2017 | $384,000 | -5.9% | 20,000 | 0.0% | 0.10% | -12.5% |
| Q3 2017 | $408,000 | +155.0% | 20,000 | +100.0% | 0.12% | +25.0% |
| Q2 2017 | $160,000 | +13.5% | 10,000 | 0.0% | 0.10% | +10.3% |
| Q1 2017 | $141,000 | – | 10,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |